We are live on ! Find out more
REPL icon

Replimune Group

101 hedge funds and large institutions have $1.05B invested in Replimune Group in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

933% more call options, than puts

Call options by funds: $31K | Put options by funds: $3K

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

0.79% more ownership

Funds ownership: 74.8%75.58% (+0.79%)

8% less funds holding

Funds holding: 110101 (-9)

22% less capital invested

Capital invested by funds: $1.34B → $1.05B (-$290M)

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
5
Increased
38
Reduced
34
Closed
14
Calls
$31K
Puts
$3K
Net Calls
+$28K
Net Calls Change
+$493K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$169M +$21M +647,590 +13%
OFM
2
Omega Fund Management
Massachusetts
$145M -$3.64M -112,171 -2%
RG
3
Redmile Group
California
$121M -$3.68M -113,400 -3%
BlackRock
4
BlackRock
New York
$61.9M +$3.48M +107,132 +5%
State Street
5
State Street
Massachusetts
$47.7M -$2.45M -75,334 -4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$46.3M +$4.39M +135,051 +9%
Ensign Peak Advisors
7
Ensign Peak Advisors
Utah
$38.2M -$5.64M -173,659 -12%
Loomis, Sayles & Company
8
Loomis, Sayles & Company
Massachusetts
$33.7M +$4.66M +143,473 +14%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$31.2M
EMFAT
10
Emerald Mutual Fund Advisers Trust
Pennsylvania
$30.1M +$8.56M +263,509 +35%
BI
11
BVF Inc
California
$27.5M +$247K +7,601 +0.8%
EA
12
Emerald Advisers
Pennsylvania
$27.3M +$6.16M +189,533 +26%
AG
13
Artal Group
Luxembourg
$26.7M
Victory Capital Management
14
Victory Capital Management
Texas
$24.7M -$2.4M -73,752 -8%
Norges Bank
15
Norges Bank
Norway
$17.8M
CS
16
Candriam SCA
Luxembourg
$15.5M +$1.17M +36,153 +7%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$14.8M +$965K +29,712 +6%
FM
18
Frazier Management
Washington
$14.6M +$16M +491,998 New
JP Morgan Chase
19
JP Morgan Chase
New York
$12.1M +$1.89M +58,079 +17%
Citadel Advisors
20
Citadel Advisors
Florida
$11.3M -$365K -11,241 -3%
Northern Trust
21
Northern Trust
Illinois
$11.3M +$177K +5,449 +1%
Wellington Management Group
22
Wellington Management Group
Massachusetts
$10.8M -$16K -493 -0.1%
Morgan Stanley
23
Morgan Stanley
New York
$10.6M -$1.19M -36,738 -9%
Amundi
24
Amundi
France
$10.5M +$2.62M +80,822 +30%
Goldman Sachs
25
Goldman Sachs
New York
$7.14M +$853K +26,252 +12%

REPL Hedge Fund Activity: Q3 2021 in Review

101 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q3 2021, worth a combined $1.05B — down 22% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of REPL and 5 opened new positions — a net loss of 9 holders — while 34 trimmed existing stakes and 38 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $21M. The largest seller was Corriente Advisors, exiting entirely with an estimated $17.3M sold.

  • 101 institutional investors held Replimune Group (REPL) as of Q3 2021, down from 110 in Q2 2021.
  • Funds reported $1.05B of Replimune Group stock for Q3 2021, down 22% quarter-over-quarter.
  • 5 funds opened new Replimune Group positions in Q3 2021 and 14 closed out, a net change of -9 holders.
  • The largest Replimune Group buyer in Q3 2021 was T. Rowe Price Associates, an estimated $21M added.
  • The largest Replimune Group seller in Q3 2021 was Corriente Advisors, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2021.